Cargando…

Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center

BACKGROUND AND OBJECTIVES: To assess the efficacy and safety of second line drugs used at our center in frequently relapsing and steroid dependant (FR/SD) childhood nephrotic syndrome. PATIENTS AND METHODS: This was a retrospective study over a period of 3 years (July 2012 to July 2015) on the use o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsaran, Khalid, Mirza, Khalid, Al-Talhi, Abdulhadi, Al-Kanani, Esam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372483/ https://www.ncbi.nlm.nih.gov/pubmed/30805504 http://dx.doi.org/10.1016/j.ijpam.2017.03.002

Ejemplares similares

A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center
por: Al Talhi, AbdulHadi, et al.
Publicado: (2018)

Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
por: Al-Akash, Samhar, et al.
Publicado: (2005)

AGREEing on clinical practice guidelines for idiopathic steroid-sensitive nephrotic syndrome in children
por: Alhasan, Khalid Abdulaziz, et al.
Publicado: (2021)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome
por: Cortazar, Frank B, et al.
Publicado: (2018)

Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic Syndrome
por: Casiraghi, Federica, et al.
Publicado: (2023)

Clinico-Biochemical Profile and Identification of Independent Risk Factors of Frequent Relapse in Childhood-Onset Steroid-Sensitive Nephrotic Syndrome
por: Behera, Manas Ranjan, et al.
Publicado: (2022)

Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome
por: Sandoval, Diego, et al.
Publicado: (2017)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience
por: Kuźma-Mroczkowska, Elżbieta, et al.
Publicado: (2016)

Efficacy of Levamisole in children with Frequent Relapsing and Steroid Dependent Nephrotic Syndrome at Tertiary Care Center-Karachi
por: Moorani, Khemchand N, et al.
Publicado: (2020)

Immunosuppressive therapy in children with steroid-resistant, frequently-relapsing, and steroid-dependent idiopathic nephrotic syndrome: a single center experience
por: Moustafa, Bahia Hassan, et al.
Publicado: (2016)

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
por: Gao, Xia, et al.
Publicado: (2021)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Mycophenolate Mofetil in the Treatment of Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children: A Meta-Analysis
por: Xiang, Xin, et al.
Publicado: (2021)

Comparison of the response of frequently relapsing steroid-dependent minimal change nephrotic syndrome to rituximab therapy between childhood-onset and adult-onset disease
por: Iwabuchi, Yuko, et al.
Publicado: (2018)

Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center Experience
por: Kim, J., et al.
Publicado: (2014)

Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
por: Tahar, Gargah, et al.
Publicado: (2010)

Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
por: Hogan, Julien, et al.
Publicado: (2020)

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
por: Hama, Taketsugu, et al.
Publicado: (2018)

Genetics of Childhood Steroid Sensitive Nephrotic Syndrome: An Update
por: Lane, Brandon M., et al.
Publicado: (2019)

Can Oral Zinc Supplementation Reduce Relapses in Childhood Steroid-Sensitive Nephrotic Syndrome? A Systematic Review
por: Mbanefo, Ngozi R, et al.
Publicado: (2023)

A Case of Frequently Relapsing Minimal-Change Nephrotic Syndrome with Steroid-Induced Psychiatric Syndrome Treated by Low-Dose, Short-Term Steroid Therapy in Combination with Cyclosporine
por: Kondo, Isao, et al.
Publicado: (2020)

Associations Between Cessation of Second-Line Therapies and Relapse Rates of Childhood Refractory Minimal-Change Nephrotic Syndrome: A Single-Center, Retrospective Chart Review
por: Jin, Jing, et al.
Publicado: (2022)

Urinary indices during relapse of childhood nephrotic syndrome
por: Iyengar, A. A., et al.
Publicado: (2011)

Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials
por: Tan, Liping, et al.
Publicado: (2019)

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07)
por: Horinouchi, Tomoko, et al.
Publicado: (2018)

The increasing incidence of initial steroid resistance in childhood nephrotic syndrome
por: Banaszak, Beata, et al.
Publicado: (2012)

Sulfatase 2 Is Associated with Steroid Resistance in Childhood Nephrotic Syndrome
por: Agrawal, Shipra, et al.
Publicado: (2021)

Steroid-resistant nephrotic syndrome: impact of genetic testing
por: Kari, Jameela A., et al.
Publicado: (2013)

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)
por: Nagano, China, et al.
Publicado: (2019)

Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis
por: Uwaezuoke, Samuel N
Publicado: (2015)

Pregnancy in 4 women with childhood-onset steroid-sensitive nephrotic syndrome
por: Motoyama, Osamu, et al.
Publicado: (2013)

Vitamin D receptor gene TaqI and Apal polymorphisms and steroid responsiveness in childhood idiopathic nephrotic syndrome
por: Al-Eisa, Amal A, et al.
Publicado: (2016)

The outcome of rituximab in treating steroid dependent nephrotic syndrome.: Histopathology and immunosuppressive drugs as predicting factors
por: Al Salloum, Abdullah A., et al.
Publicado: (2022)

Genetic analysis and outcomes of Omani children with steroid‐resistant nephrotic syndrome
por: Al Riyami, Mohamed S., et al.
Publicado: (2023)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Pulmonary surfactants and the respiratory-renal connection in steroid-sensitive nephrotic syndrome of childhood
por: Cara-Fuentes, Gabriel, et al.
Publicado: (2022)

CCL22 and Leptin associated with steroid resistance in childhood idiopathic nephrotic syndrome
por: Zhaoyang, Peng, et al.
Publicado: (2023)

Physicians' choices in the first- and second-line management of type 2 diabetes in the Kingdom of Saudi Arabia
por: Al-Rubeaan, Khalid, et al.
Publicado: (2020)

Childhood Steroid-resistant Nephrotic Syndrome: Long-term Outcomes from a Tertiary Care Center
por: Agrwal, Shipra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n45b2b4knl3n3kf08t55d96gi1